Soluble tumor necrosis factor receptors in chronic hepatitis C: A correlation with histological fibrosis and activity

Journal of Hepatology

Volumn 30, Issue 2, 1999, Pages 185-191

  Zylberberg, Hervé ^a   Rimaniol, Anne Cécile ^a   Pol, Stanislas ^a   Masson, Annie ^a   Groote, Donat De ^a   Berthelot, Pierre ^a   Bach, Jean François ^a   Bréchot, Christian ^a,b   Zavala, Flora ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b BioSource Europe SA   (Belgium)

Author keywords

Hepatitis C virus; Liver biopsy; Tumor necrosis factor; Tumor necrosis factor receptors

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CORRELATION FUNCTION; FEMALE; GENOTYPE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; VIREMIA;

EID: 0032939394     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80060-9     Document Type: Article

References (36)

1. Beutler B, Cerami A. Cachectin (tumor necrosis factor): a macrophage hormone governing cellular metabolism and inflammatory response. Endocr Rev. 9:1988;57-66.
2. Tracey KJ, Vlassara H, Cerami A. Cachectin/tumour necrosis factor. Lancet. i:1989;1122-1125.
3. Brockhaus M, Schoenfeld HJ, Schlaeger EJ, Hunziker W, Lesslauer W, Loetscher H. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA. 87:1990;3127-3131.
4. Hohmann HP, Remy R, Brockhaus M, Van Loon AP. Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha). J Biol Chem. 264:1989;14927-14934.
5. Engelmann H, Novick D, Wallach D. Two tumor necrosis factorbinding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J Biol Chem. 265:1990;1531-1536.
6. Olsson I, Lantz M, Nilsson E, Peetre C, Thysell H, Grubb A, et al. Isolation and characterization of a tumor necrosis factor binding protein from urine. Eur J Haematol. 42:1989;270-275.
7. Seckinger P, Isaaz S, Dayer JM. Purification and biologic characterization of a specific tumor necrosis factor alpha inhibitor. J Biol Chem. 264:1989;11966-11973.
8. Waage A, Liabakk N, Lien E, Lamvik J, Espevik T. p55 and p75 tumor necrosis factor receptors in patients with chronic lymphocytic leukemia. Blood. 80:1992;2577-2583.
9. Aderka D, Wysenbeek A, Engelmann H, Cope AP, Brennan F, Molad Y, et al. Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus. Arthritis Rheum. 36:1993;1111-1120.
10. Cope AP, Aderka D, Doherty M, Engelmann H, Gibbons D, Jones AC, et al. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum. 35:1992;1160-1169.
11. Van Deuren M, Van Der Ven Jongekrijg J, Demacker PN, Bartelink AK, Van Dalen R, Sauerwein RW, et al. Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections. J Infect Dis. 169:1994;157-161.
12. Calvano SE, Van Der Poll T, Coyle SM, Barie PS, Moldawer LL, Lowry SF. Monocyte tumor necrosis factor receptor levels as a predictor of risk in human sepsis. Arch Surg. 131:1996;434-437.
13. Godfried MH, Van Der Poll T, Jansen J, Romijin JA, Schattenkerk JK, Endert E, et al. Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infection. AIDS. 7:1993;33-36.
14. Bilello JA, Stellrecht K, Drusano GL, Stein DS. Soluble tumor necrosis factor-alpha receptor type II (sTNF alpha RII) correlates with human immunodeficiency virus (HIV) RNA copy number in HIV-infected patients. J Infect Dis. 173:1996;464-467.
15. Kalinkovich A, Livshits G, Engelmann H, Harpaz N, Burstein R, Kaminsky M, et al. Soluble tumour necrosis factor receptors (sTNF-R) and HIV infection: correlation to CD8+ lymphocytes. Clin Exp Immunol. 93:1993;350-355.
16. Aukrust P, Liabakk NB, Muller F, Lien E, Espevik T, Froland SS. Serum level of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection: correlations to clinical, immunologic, and virologic parameters. J Infect Dis. 169:1994;420-424.
17. Marinos G, Nikolai V, Rossol S, Torre F, Wong PYN, Gallati H, et al. Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection. Gastroenterology. 108:1995;1453-1463.
18. Gerber MA. Pathobiologic effects of hepatitis C. J Hepatol. 22:1995;83-86.
19. Yoshioka K, Kakumu S, Arao M, Tsutsumi Y, Inoue M. Tumor necrosis factor alpha production by peripheral blood mononuclear cells of patients with chronic liver disease. Hepatology. 10:1989;769-773.
20. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci USA. 89:1992;4845-4849.
21. Nophar Y, Kemper O, Brakebusch C, Englemann H, Zwang R, Aderka D, et al. Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor. EMBO J. 9:1990;3269-3278.
22. Porteu F, Hieblot C. Tumor necrosis factor induces a selective shedding of its p75 receptor from human neutrophils. J Biol Chem. 269:1994;2834-2840.
23. Porteu F, Brockhaus M, Wallach D, Engelmann H, Nathan CF. Human neutrophil elastase releases a ligand-binding fragment from the 75-kDa tumor necrosis factor (TNF) receptor. J Biol Chem. 266:1991;18846-18853.
24. Lien E, Liabakk NB, Johnsen AC, Nonstad U, Sundan A, Spevik T. Polymorphonuclear granulocytes enhance lipopolysaccharide-induced soluble p75 tumor necrosis factor receptor release from mononuclear cells. Eur J Immunol. 25:1995;2714-2717.
25. Rimaniol AC, Boussin F, Herbelin A, de Groote D, Dormont D, Bach JF, et al. Induction of soluble tumor necrosis factor receptor (sTNF-R75) release by HIV adsorption on cultured human monocytes. Eur J Immunol. 24:1994;2055-2060.
26. Joyce DA, Gibbons DP, Green P, Steer JH, Feldmann M, Brennan FM. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes. Eur J Immunol. 24:1994;2699-2705.
27. Miles DW, Aderka D, Engelmann H, Wallach D, Balkwill FR. Induction of soluble tumour necrosis factor receptors during treatment with interleukin-2. Br J Cancer. 66:1992;1195-1199.
28. Lantz M, Malik S, Slevin ML, Olsson I. Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans. Cytokine. 2:1990;402-406.
29. Higuchi M, Aggarwal BB. TNF induces internalization of the p60 receptor and shedding of the p80 receptor. J Immunol. 152:1994;3550-3558.
30. Rimaniol AC, Zylberberg H, Zavala F, Viard JP. Inflammatory cytokines and inhibitors in HIV infection: correlation between interleukin-1 receptor antagonist and weight loss. AIDS. 10:1996;1349-1356.
31. Descamps-Latscha B, Herbelin A, Nguyen AT, Roux Lombard P, Zingraff J, Moynot A, et al. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Rclationships with activation markers of T cells, B cells, and monocytes. J Immunol. 154:1995;882-892.
32. Volpes R, Van Den Oord JJ, de Vos R, Desmet VJ. Hepatic expression of type A and type B receptors for tumor necrosis factor. J Hepatol. 14:1992;361-369.
33. Engelberts I, Stephens S, Francot GJ, Van Der Linden CJ, Buurman WA. Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids. Lancet. 338:1991;515-516.
34. Larrea E, Garcia N, Qian C, Civeira MP, Prieto J. Tumor necrosis factor alpha expression and the response to interferon in chronic hepatitis C. Hepatology. 23:1996;210-217.
35. Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C. Characteristics of hepatitis C virus type II (1b) infection in France and Italy. Ann Intern Med. 122:1995;160-168.
36. Tilg H, Wolfgang V, Dinarello CA. Interferon-alpha induces circulating tumor necrosis factor receptor p55 in humans. Blood. 85:1995;433-435.